The client is required to utilize any available drug benefit before requesting the
AKDC to provide prescription coverage as the program is identified as a payer
of last resort.
The AKDC may pay up to three (3) of ESRD- related prescriptions per
month. Medication paid for by the program must be consistent with the
approved AKDC formulary. A client co-pay of $2.00 is required for each
allowable medication. Program co-payment for immuno-suppressant drugs
shall not exceed twenty percent (20%) of the Medicare allowable rate. Prior
approval is required for Fosrenol, Renvela, and Sensipar.